291 related articles for article (PubMed ID: 18718074)
1. [Factors affecting mobilization of peripheral blood stem/progenitor cells and apheresis efficiency from healthy donors by rhG-CSF].
Liang ZY; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):847-51. PubMed ID: 18718074
[TBL] [Abstract][Full Text] [Related]
2. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.
Engelhardt M; Bertz H; Afting M; Waller CF; Finke J
J Clin Oncol; 1999 Jul; 17(7):2160-72. PubMed ID: 10561272
[TBL] [Abstract][Full Text] [Related]
3. [Factors impacting yield of CD34(+) cells from healthy donors mobilized with rhG-CSF].
Zhu L; Zhou LK; Xue M; Yan HM; Liu J; Wang ZD; Ding L; Wang HX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1541-5. PubMed ID: 20030943
[TBL] [Abstract][Full Text] [Related]
4. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
5. Mobilization of hematopoietic progenitor cells with paclitaxel (taxol) as a single chemotheraupetic agent, associated with rhG-CSF.
Gómez-Espuch J; Moraleda JM; Ortuño F; Lozano ML; Ayala F; Vallejo C; de Arriba F; Vicente V
Bone Marrow Transplant; 2000 Feb; 25(3):231-5. PubMed ID: 10673692
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
[TBL] [Abstract][Full Text] [Related]
7. [Peripheral blood stem cell mobilization with low dose rhG-CSF in 56 unrelated healthy donors].
Li P; Zhang GY; Zhu P; Wu BQ; Niu Q; Xie Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):348-51. PubMed ID: 17493345
[TBL] [Abstract][Full Text] [Related]
8. Mobilization of peripheral blood stem cells with paclitaxel and rhG-CSF in high-risk breast cancer patients.
Meehan KR; Slack R; Gehan E; Herscowitz HB; Areman EM; Ebadi M; Cairo MS; Lippman ME
J Hematother Stem Cell Res; 2002 Apr; 11(2):415-21. PubMed ID: 11983113
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting PBSC mobilization and collection in healthy donors.
Lysák D; Koza V; Jindra P
Transfus Apher Sci; 2005 Nov; 33(3):275-83. PubMed ID: 16209935
[TBL] [Abstract][Full Text] [Related]
10. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
[TBL] [Abstract][Full Text] [Related]
11. Donor body mass index is an important factor that affects peripheral blood progenitor cell yield in healthy donors after mobilization with granulocyte-colony-stimulating factor.
Chen J; Burns KM; Babic A; Carrum G; Kennedy M; Segura FJ; Garcia S; Potts S; Leveque C
Transfusion; 2014 Jan; 54(1):203-10. PubMed ID: 23763340
[TBL] [Abstract][Full Text] [Related]
12. The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy.
Arat M; Arslan O; Gürman G; Dalva K; Ozcan M; Uğur A; Ilhan O
Transfus Apher Sci; 2004 Feb; 30(1):9-15. PubMed ID: 14746816
[TBL] [Abstract][Full Text] [Related]
13. Stem cell mobilization in normal donors.
Tabilio A; Falzetti F; Giannoni C; Aversa F; Martelli MP; Rossetti M; Caputo P; Chionne F; Gambelunghe C; Martelli MF
J Hematother; 1997 Jun; 6(3):227-34. PubMed ID: 9234177
[TBL] [Abstract][Full Text] [Related]
14. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF].
Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou SY; Zhou AP; Zhang CG; Ai B
Ai Zheng; 2003 Dec; 22(12):1311-6. PubMed ID: 14693058
[TBL] [Abstract][Full Text] [Related]
15. A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation.
Kröger N; Renges H; Krüger W; Gutensohn K; Löliger C; Carrero I; Cortes L; Zander AR
Br J Haematol; 2000 Dec; 111(3):761-5. PubMed ID: 11122135
[TBL] [Abstract][Full Text] [Related]
16. Mobilization and collection of PBSC in healthy donors: comparison between two schemes of rhG-CSF administration.
Majolino I; Scimé R; Vasta S; Cavallaro AM; Fiandaca T; Indovina A; Catania P; Santoro A
Eur J Haematol; 1996 Sep; 57(3):214-21. PubMed ID: 8898925
[TBL] [Abstract][Full Text] [Related]
17. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.
Cavallaro AM; Lilleby K; Majolino I; Storb R; Appelbaum FR; Rowley SD; Bensinger WI
Bone Marrow Transplant; 2000 Jan; 25(1):85-9. PubMed ID: 10654020
[TBL] [Abstract][Full Text] [Related]
18. Mobilization of peripheral blood progenitor cells for allogeneic transplantation: efficacy and toxicity of a high-dose rhG-CSF regimen.
Waller CF; Bertz H; Wenger MK; Fetscher S; Hardung M; Engelhardt M; Behringer D; Lange W; Mertelsmann R; Finke J
Bone Marrow Transplant; 1996 Aug; 18(2):279-83. PubMed ID: 8864435
[TBL] [Abstract][Full Text] [Related]
19. CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF.
de Fabritiis P; Iori AP; Mengarelli A; Gozzer M; Ferrazza G; De Propris MS; Romano A; Arcese W
Transfusion; 2001 Feb; 41(2):190-5. PubMed ID: 11239221
[TBL] [Abstract][Full Text] [Related]
20. Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis.
Körbling M; Giralt S; Khouri I; Mirza N; Donato M; Anderlini P; Fischer H; Andreeff M; McMannis J; Champlin R
J Clin Apher; 2001; 16(2):82-7. PubMed ID: 11746533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]